Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Centerspace (CSR) Financials

Centerspace logo
$66.26 -1.33 (-1.97%)
Closing price 03:59 PM Eastern
Extended Trading
$66.54 +0.29 (+0.43%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Centerspace

Annual Income Statements for Centerspace

This table shows Centerspace's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2014 4/30/2015 4/30/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-25 13 105 72 -1.79 -6.46 -21 35 -20 17
Consolidated Net Income / (Loss)
-17 29 128 85 4.74 -2.10 -18 49 -14 23
Net Income / (Loss) Continuing Operations
5.90 17 -37 83 4.74 -2.10 -19 49 -14 23
Total Pre-Tax Income
5.95 11 -37 83 4.74 -2.10 -19 49 -14 23
Total Operating Income
38 45 -24 109 34 30 14 84 20 65
Total Gross Profit
165 179 164 180 172 193 247 252 252 264
Total Revenue
165 179 170 186 178 202 257 261 261 274
Operating Revenue
165 179 170 186 178 - 257 261 261 274
Total Cost of Revenue
0.00 0.00 5.53 6.19 5.80 8.75 9.90 9.35 9.13 9.64
Operating Cost of Revenue
- - 5.53 6.19 5.80 8.75 9.90 9.35 9.13 9.64
Total Operating Expenses
127 134 188 168 138 163 233 166 231 199
Selling, General & Admin Expense
13 13 14 14 13 16 18 20 18 21
Depreciation Expense
40 43 82 74 76 92 105 102 106 113
Other Operating Expenses / (Income)
69 73 74 79 49 55 110 35 107 28
Impairment Charge
7.70 4.66 18 - - 0.00 0.00 5.22 0.00 38
Total Other Income / (Expense), net
-32 -34 -13 71 -29 -32 -33 -36 -35 -42
Interest Expense
34 34 35 33 28 32 33 36 35 42
Other Adjustments to Consolidated Net Income / (Loss)
- - - 2.09 - 0.00 1.25 - 0.00 0.00
Preferred Stock Dividends Declared
12 12 12 7.36 6.87 7.07 7.07 7.07 8.97 0.49
Net Income / (Loss) Attributable to Noncontrolling Interest
-3.77 4.60 11 5.62 -0.34 -2.71 -4.17 7.27 -3.50 5.38
Basic Earnings per Share
($0.23) $0.11 $8.71 $6.06 ($0.15) ($0.47) ($1.35) $2.33 ($1.27) $1.02
Weighted Average Basic Shares Outstanding
109.37M 124.57M 119.41M 11.74M 12.56M 13.80M 15.22M 14.99M 15.50M 16.73M
Diluted Earnings per Share
($0.23) $0.11 $8.71 $6.00 ($0.15) ($0.47) ($1.35) $2.32 ($1.27) $1.02
Weighted Average Diluted Shares Outstanding
109.37M 124.57M 119.41M 13.18M 12.56M 13.80M 15.22M 17.12M 15.50M 16.78M
Weighted Average Basic & Diluted Shares Outstanding
109.37M 124.57M 119.41M - 13.05M 15.04M 15.03M 14.91M 16.73M 16.77M
Cash Dividends to Common per Share
- - $2.80 $2.10 $2.80 $2.84 $2.92 $2.92 $3.00 $3.08

Quarterly Income Statements for Centerspace

This table shows Centerspace's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
6.17 -9.76 -5.51 -2.90 -6.17 -5.08 -3.73 -15 54 -18 -13
Consolidated Net Income / (Loss)
9.17 -9.89 -4.79 -1.66 -1.95 -5.79 -4.18 -17 65 -21 -15
Net Income / (Loss) Continuing Operations
9.17 -9.59 -4.79 -1.66 -1.95 -4.66 -4.18 -17 65 -21 -15
Total Pre-Tax Income
9.17 -9.59 -4.79 -2.14 -2.60 -4.66 -4.18 -18 64 -19 -15
Total Operating Income
17 -1.51 4.08 7.19 6.35 2.86 4.75 -6.80 77 -11 -5.39
Total Gross Profit
55 69 62 65 65 37 65 69 71 57 63
Total Revenue
65 64 65 65 65 66 67 69 71 67 65
Operating Revenue
65 - 65 65 65 - 67 69 71 67 65
Total Cost of Revenue
9.34 -4.80 2.33 0.00 0.00 29 2.43 0.00 0.00 9.64 2.38
Operating Cost of Revenue
9.34 -4.80 2.33 - - 29 2.43 - - - 2.38
Total Operating Expenses
38 69 58 58 59 34 60 75 74 -12 68
Selling, General & Admin Expense
3.83 4.36 4.62 4.22 4.10 4.86 5.00 4.38 5.00 6.54 6.33
Depreciation Expense
25 27 27 26 26 28 28 27 29 29 26
Other Operating Expenses / (Income)
9.30 32 26 28 28 1.81 27 29 31 -62 26
Impairment Charge
- - - 0.00 0.00 - 0.00 15 8.68 - 9.70
Other Special Charges / (Income)
- - - - - - 0.53 - - - -0.02
Total Other Income / (Expense), net
-8.23 -9.23 -8.87 -9.33 -8.95 -7.52 -8.93 -11 67 -88 -9.58
Interest Expense
8.23 9.29 8.87 9.33 8.95 7.52 8.93 11 13 8.23 9.58
Interest & Investment Income
- - - 0.00 0.00 - - 0.00 80 - 0.00
Preferred Stock Dividends Declared
1.77 1.77 1.77 1.77 5.28 0.16 0.16 0.16 0.11 0.06 0.06
Net Income / (Loss) Attributable to Noncontrolling Interest
1.24 -1.89 -1.05 -0.53 -1.06 -0.87 -0.61 -2.43 12 -3.10 -2.14
Basic Earnings per Share
$0.41 ($0.64) ($0.37) ($0.19) ($0.40) ($0.31) ($0.22) ($0.87) $3.22 ($1.11) ($0.77)
Weighted Average Basic Shares Outstanding
14.99M 14.99M 14.92M 14.97M 15.53M 15.50M 16.73M 16.74M 16.73M 16.73M 16.78M
Diluted Earnings per Share
$0.41 ($0.62) ($0.37) ($0.19) ($0.40) ($0.31) ($0.22) ($0.87) $3.19 ($1.08) ($0.77)
Weighted Average Diluted Shares Outstanding
18.02M 17.12M 14.92M 14.97M 15.53M 15.50M 16.73M 16.74M 19.77M 16.78M 16.78M
Weighted Average Basic & Diluted Shares Outstanding
15.05M 14.91M 14.91M 15.30M 16.57M 16.73M 16.74M 16.76M 16.70M 16.77M 16.80M
Cash Dividends to Common per Share
$0.73 - $0.75 - $0.75 - $0.77 - $0.77 - $0.77

Annual Cash Flow Statements for Centerspace

This table details how cash moves in and out of Centerspace's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
1.70 11 -15 -41 27 -39 31 -27 -2.62 3.86 2.52
Net Cash From Operating Activities
114 72 79 55 70 61 84 92 90 98 98
Net Cash From Continuing Operating Activities
114 72 79 55 70 61 84 92 90 98 98
Net Income / (Loss) Continuing Operations
29 77 31 128 85 4.74 -2.10 -18 49 -14 23
Consolidated Net Income / (Loss)
29 77 31 128 85 4.74 -2.10 -18 49 -14 23
Depreciation Expense
72 65 57 92 75 77 93 106 103 108 115
Amortization Expense
- - - - - - - - -0.23 1.18 1.92
Non-Cash Adjustments To Reconcile Net Income
3.13 -58 -10 -156 -94 -16 -17 3.17 -60 6.35 -36
Changes in Operating Assets and Liabilities, net
10 -12 2.22 -8.50 3.01 -3.76 10 0.01 -2.87 -3.46 -5.37
Net Cash From Investing Activities
-176 129 224 80 7.01 -165 -267 -160 120 -51 -27
Net Cash From Continuing Investing Activities
-176 129 224 80 7.01 -165 -267 -160 120 -51 -27
Purchase of Property, Plant & Equipment
-60 -149 0.00 -392 -179 -199 -306 -57 -59 -57 -34
Purchase of Investments
- - 0.00 0.00 -6.94 - - -105 -42 -1.03 -206
Sale and/or Maturity of Investments
74 40 47 65 199 48 61 0.04 223 18 212
Other Investing Activities, net
-190 237 177 -19 -5.91 -13 -22 1.10 -2.00 -11 1.31
Net Cash From Financing Activities
64 -189 -318 -176 -50 65 215 41 -212 -44 -69
Net Cash From Continuing Financing Activities
64 -189 -318 -176 -50 65 215 41 -212 -44 -69
Repayment of Debt
-157 -391 -555 -530 -431 -86 -343 -84 -366 -124 -445
Repurchase of Preferred Equity
0.00 0.00 -29 -115 0.00 -5.63 - 0.00 0.00 -97 -11
Repurchase of Common Equity
0.00 -35 -5.47 -19 -26 -0.05 0.00 -33 -12 -4.70 -3.45
Payment of Dividends
-69 -86 -79 -47 -44 -45 -50 -61 -60 -60 -65
Issuance of Debt
239 320 349 443 430 155 455 192 225 131 455
Issuance of Common Equity
51 2.61 9.75 0.00 22 59 156 31 0.00 112 1.10
Other Financing Activities, net
0.00 0.00 -9.21 -7.90 -1.26 -12 -3.80 -3.21 0.00 0.00 -1.17
Cash Interest Paid
51 40 34 36 29 26 27 31 34 34 41

Quarterly Cash Flow Statements for Centerspace

This table details how cash moves in and out of Centerspace's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
42 -43 4.48 1.66 1.84 -4.12 4.93 0.13 48 -50 -5.39
Net Cash From Operating Activities
32 12 24 23 32 19 25 25 35 13 21
Net Cash From Continuing Operating Activities
32 12 24 23 32 19 25 25 35 13 21
Net Income / (Loss) Continuing Operations
9.17 -9.89 -4.79 -1.66 -1.95 -5.79 -4.18 -17 65 -21 -15
Consolidated Net Income / (Loss)
9.17 -9.89 -4.79 -1.66 -1.95 -5.79 -4.18 -17 65 -21 -15
Depreciation Expense
25 27 27 26 26 28 28 27 29 30 27
Amortization Expense
- - 0.26 - - - 0.41 0.41 0.52 0.58 0.36
Non-Cash Adjustments To Reconcile Net Income
-10 4.58 1.59 2.12 2.29 1.98 1.61 16 -70 17 12
Changes in Operating Assets and Liabilities, net
7.25 -9.23 0.04 -3.61 5.06 -4.94 -0.38 -1.91 9.68 -13 -2.69
Net Cash From Investing Activities
68 -65 -9.03 -19 -12 -10 -4.89 -160 57 80 -5.02
Net Cash From Continuing Investing Activities
68 -65 -9.03 -19 -12 -10 -4.89 -160 57 80 -5.02
Purchase of Property, Plant & Equipment
-14 -19 -22 -14 -12 -10 -5.04 -9.73 -9.35 -10 -5.32
Other Investing Activities, net
0.79 -3.52 -5.47 -5.61 -0.19 -0.01 0.16 0.22 0.59 0.34 0.29
Net Cash From Financing Activities
-58 10 -11 -1.81 -18 -13 -16 134 -45 -143 -22
Net Cash From Continuing Financing Activities
-58 10 -11 -1.81 -18 -13 -16 134 -45 -143 -22
Repayment of Debt
-57 -29 -32 -12 -61 -19 -46 -38 -134 -227 -31
Payment of Dividends
-15 -15 -15 -15 -15 -15 -15 -15 -15 -20 -15
Issuance of Debt
14 59 41 18 50 22 45 193 113 104 25
Other Financing Activities, net
- - - - - - 0.00 - - - -0.42
Cash Interest Paid
14 7.99 8.30 8.80 7.70 10 8.64 7.79 14 11 9.53

Annual Balance Sheets for Centerspace

This table presents Centerspace's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,998 1,755 1,475 1,336 1,392 1,464 1,940 2,033 1,926 1,914 1,926
Total Current Assets
54 71 29 14 46 7.31 39 12 9.27 13 16
Cash & Equivalents
49 67 29 14 27 0.39 31 10 8.63 12 13
Restricted Cash
- - - - 20 6.92 7.36 1.43 0.64 1.10 2.82
Plant, Property, & Equipment, net
1.03 1.01 1,103 1,274 1,294 1,413 1,828 -535 1,889 1,855 1,864
Plant, Property & Equipment, gross
1,336 1,681 1,359 1,628 1,643 1,813 2,271 - 2,420 2,481 2,524
Accumulated Depreciation
279 313 256 354 349 399 444 535 531 626 660
Total Noncurrent Assets
1,942 1,683 343 48 52 44 74 2,557 28 46 47
Other Noncurrent Operating Assets
1,263 1,459 41 33 35 19 31 23 28 46 47
Total Liabilities & Shareholders' Equity
1,998 1,755 1,475 1,336 1,392 1,464 1,940 2,033 1,926 1,914 1,926
Total Liabilities
1,251 1,029 831 687 696 775 918 1,066 979 1,015 1,080
Total Current Liabilities
116 57 36 41 47 56 62 59 63 59 59
Accounts Payable
56 40 36 41 47 56 62 59 63 59 59
Total Noncurrent Liabilities
1,134 972 796 646 649 719 856 1,008 916 955 1,021
Long-Term Debt
597 812 623 646 649 719 856 1,008 916 955 1,021
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
6.37 7.52 7.18 5.97 17 17 25 17 17 17 5.94
Total Equity & Noncontrolling Interests
741 718 636 643 680 673 996 950 931 882 840
Total Preferred & Common Equity
652 619 561 569 619 618 772 730 710 752 719
Total Common Equity
513 480 450 469 520 525 679 636 616 752 719
Common Stock
952 922 916 899 917 968 1,157 1,177 1,166 1,368 1,369
Retained Earnings
-438 -442 -467 -429 -390 -428 -474 -539 -548 -615 -650
Noncontrolling Interest
89 100 75 75 61 55 224 221 221 130 121

Quarterly Balance Sheets for Centerspace

This table presents Centerspace's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
2,039 1,979 1,920 1,878 1,903 1,899 1,887 1,893 2,013 2,098 1,888
Total Current Assets
16 58 10 52 14 15 17 18 156 152 10
Cash & Equivalents
15 8.94 9.75 30 13 14 14 12 12 13 7.56
Restricted Cash
1.42 49 0.57 22 1.07 1.08 2.79 6.14 5.82 53 2.71
Plant, Property, & Equipment, net
2,002 1,902 -543 -517 -553 -579 1,834 1,832 1,810 1,898 1,832
Plant, Property & Equipment, gross
2,513 2,421 - - - - 2,438 2,484 2,422 2,536 2,518
Accumulated Depreciation
511 519 543 517 553 579 604 652 613 638 686
Total Noncurrent Assets
20 19 2,453 2,343 2,443 2,463 36 43 48 48 45
Other Noncurrent Operating Assets
20 19 19 16 29 34 36 43 48 48 45
Total Liabilities & Shareholders' Equity
2,039 1,979 1,920 1,878 1,903 1,899 1,887 1,893 2,013 2,098 1,888
Total Liabilities
1,026 975 938 901 980 985 982 1,013 1,168 1,211 1,072
Total Current Liabilities
58 57 57 63 55 53 61 58 56 66 56
Accounts Payable
58 57 57 63 55 53 61 58 56 66 56
Total Noncurrent Liabilities
967 918 881 839 925 932 921 955 1,112 1,145 1,016
Long-Term Debt
967 918 881 839 925 932 921 955 1,111 1,144 1,016
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
17 17 17 17 17 17 17 17 11 5.94 5.94
Total Equity & Noncontrolling Interests
996 988 965 960 907 898 889 863 834 881 810
Total Preferred & Common Equity
776 759 738 734 688 681 672 637 710 749 695
Total Common Equity
683 666 645 640 595 587 672 637 710 749 695
Common Stock
1,210 1,176 1,170 1,169 1,160 1,167 1,271 1,269 1,369 1,367 1,370
Retained Earnings
-525 -508 -523 -528 -565 -579 -598 -632 -659 -618 -675
Noncontrolling Interest
220 229 227 227 219 218 216 227 124 132 115

Annual Metrics And Ratios for Centerspace

This table displays calculated financial ratios and metrics derived from Centerspace's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 4/30/2015 4/30/2016 4/30/2017 4/30/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
8.95% 5.02% 0.00% 0.00% 9.43% -4.18% 13.32% 27.27% 1.79% -0.12% 4.86%
EBITDA Growth
5.57% -7.64% -47.93% 55.83% 116.55% -42.19% 11.38% -2.38% 56.26% -31.71% 40.06%
EBIT Growth
20.78% -5.18% -100.00% 0.00% 3,326.20% -70.73% -11.67% -53.63% 509.29% -75.76% 215.20%
NOPAT Growth
19.65% -12.00% -100.00% 0.00% 757.16% -68.96% -38.17% -53.63% 770.41% -83.03% 350.28%
Net Income Growth
269.33% 167.05% 0.00% 0.00% -33.54% -94.41% -144.30% -739.65% 379.07% -128.83% 261.81%
EPS Growth
147.83% 345.45% 0.00% 0.00% -31.11% -102.50% -213.33% -187.23% 271.85% -154.74% 180.32%
Operating Cash Flow Growth
23.42% -41.76% 11.18% -30.18% 26.14% -12.06% 37.24% 9.48% -2.69% 9.75% 0.21%
Free Cash Flow Firm Growth
936.24% -133.98% 223.80% -180.90% 138.67% -179.80% -498.48% 680.61% -196.74% 101.17% 98.92%
Invested Capital Growth
-36.39% 24.50% -20.73% 19.60% 1.71% 7.97% 31.24% -131.08% 424.45% -0.71% 0.54%
Revenue Q/Q Growth
51.16% 13.60% 0.00% 0.00% 3.60% -0.13% 6.58% 3.99% -1.43% 0.91% 0.08%
EBITDA Q/Q Growth
21.20% 5.70% 25.43% 19.14% -30.42% -31.09% -13.82% 4.25% -3.90% 4.41% -5.10%
EBIT Q/Q Growth
76.82% 23.16% 100.00% 0.00% 17.51% -60.16% -49.91% 208.78% -9.06% 27.08% -17.28%
NOPAT Q/Q Growth
77.41% 14.57% 100.00% 0.00% 281.78% -60.16% -64.93% 208.78% -9.06% 27.08% -17.28%
Net Income Q/Q Growth
245.60% -2.68% 0.00% 0.00% 0.00% 0.00% -203.40% 26.13% -12.94% 22.41% -40.59%
EPS Q/Q Growth
144.00% 0.00% 0.00% 0.00% 0.00% 0.00% -88.00% 24.58% -14.39% 19.62% -43.02%
Operating Cash Flow Q/Q Growth
0.88% -17.24% -1.76% -17.04% 9.38% -6.15% 19.49% -4.82% -10.87% 7.16% -5.71%
Free Cash Flow Firm Q/Q Growth
2,367.90% -165.56% 195.51% -341.46% -35.80% -235.63% -18.62% 1,587.52% -189.38% 101.16% 595.94%
Invested Capital Q/Q Growth
-38.11% -6.38% -19.84% -7.68% -4.11% 1.03% 2.28% -129.10% 429.37% 1.77% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 0.00% 96.74% 96.67% 96.74% 95.66% 96.15% 96.42% 86.19% 96.48%
EBITDA Margin
65.64% 57.73% 0.00% 51.97% 102.84% 62.05% 60.98% 46.77% 71.80% 49.09% 66.18%
Operating Margin
25.04% 20.98% 0.00% -13.96% 58.70% 19.01% 14.82% 5.40% 32.32% 7.85% 23.58%
EBIT Margin
25.44% 22.97% 0.00% -2.11% 62.25% 19.01% 14.82% 5.40% 32.32% 7.85% 23.58%
Profit (Net Income) Margin
16.00% 40.68% 0.00% 75.19% 45.66% 2.66% -1.04% -6.87% 18.84% -5.44% 8.39%
Tax Burden Percent
255.26% 794.63% 0.00% -343.14% 102.53% 100.00% 100.00% 93.60% 100.00% 100.00% 100.00%
Interest Burden Percent
24.63% 22.28% 0.00% 1,037.78% 71.55% 14.01% -7.03% -135.98% 58.29% -69.31% 35.58%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
3.23% 3.26% 0.00% -1.42% 8.47% 2.51% 1.29% 1.53% 13.17% 0.78% 3.50%
ROIC Less NNEP Spread (ROIC-NNEP)
0.75% 11.03% 0.00% 26.05% 4.53% -1.92% -1.72% 9.12% 24.32% -2.31% -0.77%
Return on Net Nonoperating Assets (RNNOA)
0.66% 7.14% 0.00% 21.16% 4.13% -1.82% -1.54% -3.31% -8.02% -2.31% -0.86%
Return on Equity (ROE)
3.89% 10.40% 0.00% 19.75% 12.60% 0.68% -0.25% -1.77% 5.14% -1.54% 2.63%
Cash Return on Invested Capital (CROIC)
47.71% -18.57% 23.12% -19.27% 6.78% -5.16% -25.73% 0.00% -126.27% 1.48% 2.95%
Operating Return on Assets (OROA)
2.36% 2.31% 0.00% -0.26% 8.48% 2.37% 1.76% 0.70% 4.27% 1.07% 3.36%
Return on Assets (ROA)
1.48% 4.08% 0.00% 9.08% 6.22% 0.33% -0.12% -0.89% 2.49% -0.74% 1.20%
Return on Common Equity (ROCE)
2.55% 7.01% 0.00% 14.04% 9.26% 0.52% -0.17% -1.17% 3.36% -1.06% 2.22%
Return on Equity Simple (ROE_SIMPLE)
4.40% 12.38% 5.44% 22.44% 13.70% 0.77% -0.27% -2.42% 6.94% -2.17% 0.00%
Net Operating Profit after Tax (NOPAT)
45 40 0.00 -17 109 34 21 9.70 84 14 65
NOPAT Margin
25.04% 20.98% 0.00% -9.78% 58.70% 19.01% 10.37% 3.78% 32.32% 5.49% 23.58%
Net Nonoperating Expense Percent (NNEP)
2.48% -7.78% 0.00% -27.46% 3.94% 4.43% 3.01% -7.59% -11.15% 3.09% 4.27%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 0.50% 4.57% 0.78% 3.47%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 3.26% 3.33% 3.26% 4.34% 3.85% 3.58% 13.81% 3.52%
SG&A Expenses to Revenue
7.51% 7.17% 0.00% 8.40% 7.78% 7.55% 8.04% 6.82% 7.68% 6.82% 7.64%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
74.96% 79.02% 0.00% 110.71% 90.52% 77.73% 80.84% 90.76% 63.64% 78.35% 72.90%
Earnings before Interest and Taxes (EBIT)
46 43 0.00 -3.58 116 34 30 14 84 20 65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
118 109 57 88 191 110 123 120 188 128 181
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.07 0.00 0.00 1.04 1.34 1.51 2.08 1.26 1.36 1.68 1.55
Price to Tangible Book Value (P/TBV)
1.08 0.00 0.00 1.04 1.34 1.51 2.08 1.26 1.36 1.68 1.55
Price to Revenue (P/Rev)
3.06 0.00 0.00 2.87 3.75 4.44 7.00 3.12 3.20 4.20 4.07
Price to Earnings (P/E)
43.66 0.00 0.00 4.66 9.69 0.00 0.00 0.00 23.96 0.00 65.17
Dividend Yield
11.61% 0.00% 0.00% 6.90% 4.68% 4.60% 2.87% 5.49% 5.26% 4.54% 4.62%
Earnings Yield
2.29% 0.00% 0.00% 21.47% 10.32% 0.00% 0.00% 0.00% 4.17% 0.00% 1.53%
Enterprise Value to Invested Capital (EV/IC)
1.29 0.00 0.00 1.01 1.14 1.19 1.40 0.00 1.12 1.24 1.21
Enterprise Value to Revenue (EV/Rev)
7.76 0.00 0.00 7.62 7.94 9.37 12.75 0.00 7.94 8.75 8.21
Enterprise Value to EBITDA (EV/EBITDA)
11.82 0.00 0.00 14.66 7.72 15.10 20.91 0.00 11.06 17.82 12.40
Enterprise Value to EBIT (EV/EBIT)
30.49 0.00 0.00 0.00 12.75 49.26 86.05 0.00 24.56 111.53 34.81
Enterprise Value to NOPAT (EV/NOPAT)
30.98 0.00 0.00 0.00 13.52 49.26 122.93 0.00 24.56 159.33 34.81
Enterprise Value to Operating Cash Flow (EV/OCF)
12.18 0.00 0.00 23.44 21.17 27.23 30.61 0.00 23.17 23.24 22.82
Enterprise Value to Free Cash Flow (EV/FCFF)
2.10 0.00 0.00 0.00 16.89 0.00 0.00 0.00 0.00 83.31 41.20
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.88 1.14 0.97 0.99 0.93 1.04 0.84 1.04 0.97 1.06 1.21
Long-Term Debt to Equity
0.80 1.12 0.97 0.99 0.93 1.04 0.84 1.04 0.97 1.06 1.21
Financial Leverage
0.89 0.65 0.76 0.81 0.91 0.95 0.89 -0.36 -0.33 1.00 1.12
Leverage Ratio
2.62 2.55 2.36 2.17 2.03 2.06 1.99 2.00 2.07 2.08 2.20
Compound Leverage Factor
0.65 0.57 0.00 22.56 1.45 0.29 -0.14 -2.72 1.21 -1.44 0.78
Debt to Total Capital
46.80% 53.35% 49.20% 49.86% 48.23% 51.06% 45.59% 51.03% 49.15% 51.52% 54.70%
Short-Term Debt to Total Capital
4.31% 1.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
42.50% 52.22% 49.20% 49.86% 48.23% 51.06% 45.59% 51.03% 49.15% 51.52% 54.70%
Preferred Equity to Total Capital
9.87% 8.91% 8.79% 7.68% 7.39% 6.64% 4.98% 4.74% 5.02% 0.00% 0.00%
Noncontrolling Interests to Total Capital
6.78% 6.88% 6.50% 6.23% 5.75% 5.05% 13.29% 12.02% 12.76% 13.22% 6.78%
Common Equity to Total Capital
36.55% 30.86% 35.50% 36.24% 38.62% 37.25% 36.14% 32.21% 33.07% 35.26% 38.52%
Debt to EBITDA
5.59 7.63 11.01 7.32 3.40 6.51 6.96 8.39 4.88 7.46 5.64
Net Debt to EBITDA
5.17 7.02 10.17 7.10 3.15 6.45 6.65 -12.81 4.83 7.35 5.55
Long-Term Debt to EBITDA
5.07 7.47 11.01 7.32 3.40 6.51 6.96 8.39 4.88 7.46 5.64
Debt to NOPAT
14.64 21.00 0.00 -38.91 5.95 21.25 40.91 103.85 10.85 66.66 15.82
Net Debt to NOPAT
13.54 19.31 0.00 -37.76 5.51 21.03 39.07 -158.55 10.74 65.74 15.58
Long-Term Debt to NOPAT
13.29 20.56 0.00 -38.91 5.95 21.25 40.91 103.85 10.85 66.66 15.82
Altman Z-Score
0.08 0.00 0.00 0.07 0.61 0.36 0.72 0.20 0.36 0.34 0.37
Noncontrolling Interest Sharing Ratio
34.40% 32.56% 32.09% 28.92% 26.52% 24.65% 29.68% 33.89% 34.59% 31.21% 15.68%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.47 1.24 0.81 0.34 0.98 0.13 0.62 0.20 0.15 0.22 0.26
Quick Ratio
0.44 1.19 0.81 0.34 0.56 0.01 0.50 0.18 0.14 0.20 0.22
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
663 -225 279 -226 87 -70 -417 2,420 -2,341 27 55
Operating Cash Flow to CapEx
190.20% 0.00% 0.00% 0.00% 38.81% 30.77% 27.45% 162.62% 152.18% 170.32% 288.20%
Free Cash Flow to Firm to Interest Expense
19.25 -6.28 0.00 -6.43 2.65 -2.53 -13.03 73.90 -64.27 0.79 1.31
Operating Cash Flow to Interest Expense
3.31 1.85 0.00 1.57 2.12 2.22 2.63 2.81 2.46 2.83 2.37
Operating Cash Flow Less CapEx to Interest Expense
1.57 7.91 0.00 2.54 -3.34 -5.01 -6.94 1.08 0.84 1.17 1.55
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.09 0.10 0.00 0.12 0.14 0.12 0.12 0.13 0.13 0.14 0.14
Accounts Receivable Turnover
28.47 96.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
132.44 184.81 0.00 0.14 0.14 0.13 0.12 0.00 0.00 0.14 0.15
Accounts Payable Turnover
0.00 0.00 0.00 0.14 0.14 0.11 0.15 0.16 0.15 0.59 0.16
Days Sales Outstanding (DSO)
12.82 3.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 2,525.08 2,597.57 3,232.97 2,460.83 2,235.65 2,372.05 618.26 2,245.10
Cash Conversion Cycle (CCC)
12.82 3.79 0.00 -2,525.08 -2,597.57 -3,232.97 -2,460.83 -2,235.65 -2,372.05 -618.26 -2,245.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,081 1,346 1,067 1,276 1,298 1,401 1,839 -572 1,854 1,841 1,851
Invested Capital Turnover
0.13 0.16 0.00 0.14 0.14 0.13 0.12 0.41 0.41 0.14 0.15
Increase / (Decrease) in Invested Capital
-618 265 -279 209 22 103 438 -2,411 2,426 -13 10
Enterprise Value (EV)
1,391 0.00 0.00 1,294 1,474 1,667 2,572 -405 2,074 2,284 2,247
Market Capitalization
549 0.00 0.00 487 696 791 1,412 802 836 1,096 1,114
Book Value per Share
$4.19 $3.96 $0.00 $3.91 $44.70 $40.43 $47.51 $42.21 $40.94 $39.46 $43.05
Tangible Book Value per Share
$4.16 $3.94 $0.00 $3.91 $44.70 $40.43 $47.51 $42.21 $40.94 $39.46 $43.05
Total Capital
1,405 1,556 1,266 1,295 1,345 1,409 1,878 1,974 1,864 1,854 1,867
Total Debt
657 830 623 646 649 719 856 1,008 916 955 1,021
Total Long-Term Debt
597 812 623 646 649 719 856 1,008 916 955 1,021
Net Debt
608 763 576 627 601 712 817 -1,538 907 942 1,006
Capital Expenditures (CapEx)
60 -217 -196 -34 179 199 306 57 59 58 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-50 -35 -36 -41 -47 -56 -62 -59 -63 -59 -59
Debt-free Net Working Capital (DFNWC)
-1.05 31 -6.75 -27 -1.04 -48 -24 -47 -53 -46 -44
Net Working Capital (NWC)
-62 14 -6.75 -27 -1.04 -48 -24 -47 -53 -46 -44
Net Nonoperating Expense (NNE)
16 -37 0.00 -144 24 29 23 27 35 29 42
Net Nonoperating Obligations (NNO)
334 620 424 627 601 712 817 -1,538 907 942 1,006
Total Depreciation and Amortization (D&A)
72 65 57 92 75 77 93 106 103 108 117
Debt-free, Cash-free Net Working Capital to Revenue
-27.89% -18.73% 0.00% -24.09% -25.39% -31.24% -30.94% -22.91% -24.02% -22.73% -21.65%
Debt-free Net Working Capital to Revenue
-0.58% 16.69% 0.00% -15.97% -0.56% -27.14% -11.79% -18.28% -20.47% -17.70% -15.93%
Net Working Capital to Revenue
-34.32% 7.40% 0.00% -15.97% -0.56% -27.14% -11.79% -18.28% -20.47% -17.70% -15.93%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.10 $0.49 $0.00 $8.70 $0.00 ($0.15) ($0.47) ($1.35) $2.33 ($1.27) $1.02
Adjusted Weighted Average Basic Shares Outstanding
12.46M 121.09M 0.00 11.94M 0.00 13.05M 13.80M 15.22M 14.99M 15.50M 16.73M
Adjusted Diluted Earnings per Share
$1.10 $0.49 $0.00 $8.70 $0.00 ($0.15) ($0.47) ($1.35) $2.32 ($1.27) $1.02
Adjusted Weighted Average Diluted Shares Outstanding
12.46M 121.09M 0.00 11.94M 0.00 13.05M 15.70M 15.22M 17.12M 15.50M 16.78M
Adjusted Basic & Diluted Earnings per Share
$1.10 $0.49 $0.00 $8.70 $0.00 ($0.15) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
12.46M 121.09M 0.00 11.94M 0.00 13.05M 15.04M 15.03M 14.91M 16.73M 16.77M
Normalized Net Operating Profit after Tax (NOPAT)
35 32 0.00 -3.95 76 24 21 9.70 65 14 72
Normalized NOPAT Margin
19.49% 17.06% 0.00% -2.33% 41.09% 13.31% 10.37% 3.78% 25.06% 5.49% 26.16%
Pre Tax Income Margin
6.27% 5.12% 0.00% -21.91% 44.54% 2.66% -1.04% -7.34% 18.84% -5.44% 8.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.32 1.21 0.00 -0.10 3.51 1.23 0.93 0.42 2.32 0.59 1.55
NOPAT to Interest Expense
1.30 1.10 0.00 -0.47 3.31 1.23 0.65 0.30 2.32 0.41 1.55
EBIT Less CapEx to Interest Expense
-0.42 7.26 0.00 0.87 -1.94 -6.00 -8.63 -1.30 0.70 -1.07 0.73
NOPAT Less CapEx to Interest Expense
-0.44 7.15 0.00 0.50 -2.14 -6.00 -8.91 -1.43 0.70 -1.25 0.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
241.04% 111.89% 0.00% 36.55% 51.54% 951.15% -2,402.24% -347.63% 122.57% -425.32% 283.75%
Augmented Payout Ratio
241.04% 157.58% 0.00% 51.21% 82.39% 952.20% -2,402.24% -535.83% 146.08% -458.46% 298.79%

Quarterly Metrics And Ratios for Centerspace

This table displays calculated financial ratios and metrics derived from Centerspace's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 16,774,337.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 16,774,337.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.77
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.33% -5.57% -4.99% 0.41% 0.71% 3.65% 4.01% 5.39% 9.80% 0.32% -3.02%
EBITDA Growth
36.61% -23.05% -64.84% 8.46% -22.74% 21.30% 4.70% -37.04% 224.85% -36.76% -34.14%
EBIT Growth
147.40% -121.79% -93.49% 20.55% -63.50% 289.90% 16.47% -194.49% 1,115.91% -471.69% -213.63%
NOPAT Growth
253.43% -121.79% -95.44% 20.55% -74.45% 289.90% 16.47% -194.49% 1,637.01% -471.69% -213.63%
Net Income Growth
1,290.78% -285.38% -109.16% 30.13% -121.28% 41.47% 12.75% -909.32% 3,452.54% -271.21% -258.12%
EPS Growth
392.86% -169.57% -113.41% 17.39% -197.56% 50.00% 40.54% -357.89% 897.50% -248.39% -250.00%
Operating Cash Flow Growth
-7.61% -47.43% 11.92% -3.77% 1.44% 54.26% 4.20% 10.52% 8.46% -31.92% -15.75%
Free Cash Flow Firm Growth
1,681.03% -200.48% 2,403.59% -99.14% -193.06% 100.62% -197.83% -11,431.31% 100.30% -215.69% 99.67%
Invested Capital Growth
-128.67% 424.45% -131.02% -2.78% 421.34% -0.71% 414.22% 401.70% 3.88% 0.54% 0.22%
Revenue Q/Q Growth
-0.32% -0.77% 0.68% 0.83% -0.03% 2.13% 1.03% 2.17% 4.16% -6.69% -2.33%
EBITDA Q/Q Growth
38.40% -40.04% 23.53% 5.80% -1.42% -5.86% 7.51% -36.41% 408.72% -81.58% 10.49%
EBIT Q/Q Growth
191.57% -108.65% 370.76% 76.49% -11.71% -54.99% 66.06% -243.19% 1,236.11% -113.76% 49.23%
NOPAT Q/Q Growth
316.53% -106.06% 370.76% 76.49% -11.71% -54.99% 66.06% -243.19% 1,723.01% -109.63% 49.23%
Net Income Q/Q Growth
485.25% -207.81% 51.52% 65.30% -17.32% -196.57% 27.74% -301.46% 489.68% -132.84% 30.29%
EPS Q/Q Growth
278.26% -251.22% 40.32% 48.65% -110.53% 22.50% 29.03% -295.45% 466.67% -133.86% 28.70%
Operating Cash Flow Q/Q Growth
34.10% -62.02% 101.68% -6.32% 41.37% -42.25% 36.24% -0.64% 38.74% -63.75% 68.59%
Free Cash Flow Firm Q/Q Growth
3.02% -195.39% 36,216.55% -99.13% -11,262.45% 100.64% -15,965.46% -0.46% 100.29% -348.27% 55.11%
Invested Capital Q/Q Growth
3.10% 429.37% -2.22% -3.25% 402.96% 1.77% -1.30% -0.87% 4.31% -1.49% -1.61%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
85.53% 107.50% 96.39% 96.58% 96.55% 55.97% 100.00% 100.00% 100.00% 85.53% 96.34%
EBITDA Margin
65.61% 39.65% 48.65% 51.04% 50.33% 46.40% 49.37% 30.73% 150.09% 29.64% 33.53%
Operating Margin
26.94% -2.35% 6.32% 11.06% 9.77% 4.30% 7.07% -9.91% 108.14% -15.95% -8.29%
EBIT Margin
26.94% -2.35% 6.32% 11.06% 9.77% 4.30% 7.07% -9.91% 108.14% -15.95% -8.29%
Profit (Net Income) Margin
14.20% -15.43% -7.43% -2.56% -3.00% -8.71% -6.23% -24.49% 91.61% -32.24% -23.01%
Tax Burden Percent
100.00% 103.08% 100.00% 77.71% 75.15% 124.06% 85.52% 95.80% 101.85% 113.95% 100.00%
Interest Burden Percent
52.71% 637.21% -117.60% -29.76% -40.88% -163.19% -103.01% 257.80% 83.18% 177.43% 277.64%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
10.20% -0.67% 1.77% 0.00% 2.84% 0.43% 2.11% -3.08% 16.03% -1.65% -0.87%
ROIC Less NNEP Spread (ROIC-NNEP)
12.99% 2.13% 4.16% 0.00% 4.85% -0.42% 4.76% 1.25% 14.79% -3.10% -2.02%
Return on Net Nonoperating Assets (RNNOA)
-3.84% -0.70% -1.38% 0.00% -1.64% -0.42% -1.49% -0.40% 15.65% -3.46% -2.31%
Return on Equity (ROE)
6.35% -1.37% 0.39% -0.76% 1.20% 0.01% 0.62% -3.47% 31.68% -5.11% -3.18%
Cash Return on Invested Capital (CROIC)
0.00% -126.27% 0.00% 0.00% -130.50% 1.48% -131.01% -132.87% 0.42% 2.95% 2.77%
Operating Return on Assets (OROA)
3.65% -0.31% 0.84% 1.49% 1.34% 0.59% 0.98% -1.35% 14.84% -2.27% -1.19%
Return on Assets (ROA)
1.92% -2.04% -0.99% -0.35% -0.41% -1.18% -0.87% -3.34% 12.57% -4.60% -3.31%
Return on Common Equity (ROCE)
4.22% -0.90% 0.26% -0.49% 0.84% 0.01% 0.42% -2.56% 25.13% -4.31% -2.50%
Return on Equity Simple (ROE_SIMPLE)
7.71% 0.00% -1.15% -1.05% -2.72% 0.00% -2.13% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
17 -1.05 2.85 5.03 4.45 2.00 3.32 -4.76 77 -7.44 -3.78
NOPAT Margin
26.94% -1.64% 4.42% 7.74% 6.84% 3.01% 4.95% -6.94% 108.14% -11.16% -5.80%
Net Nonoperating Expense Percent (NNEP)
-2.79% -2.80% -2.38% -0.44% -2.01% 0.84% -2.66% -4.33% 1.24% 1.44% 1.15%
Return On Investment Capital (ROIC_SIMPLE)
- -0.06% - - - 0.11% 0.18% -0.24% 3.81% -0.40% -0.21%
Cost of Revenue to Revenue
14.47% -7.50% 3.61% 3.42% 3.45% 44.03% 0.00% 0.00% 0.00% 14.47% 3.66%
SG&A Expenses to Revenue
5.93% 6.81% 7.17% 6.48% 6.31% 7.32% 7.45% 6.39% 7.00% 9.82% 9.73%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
58.59% 108.06% 90.07% 85.53% 86.79% 51.67% 92.93% 109.91% 103.25% -17.90% 104.63%
Earnings before Interest and Taxes (EBIT)
17 -1.51 4.08 7.19 6.35 2.86 4.75 -6.80 77 -11 -5.39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
42 25 31 33 33 31 33 21 107 20 22
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.34 1.36 1.43 1.72 1.60 1.68 1.70 1.42 1.32 1.55 1.39
Price to Tangible Book Value (P/TBV)
1.34 1.36 1.43 1.72 1.60 1.68 1.70 1.42 1.32 1.55 1.39
Price to Revenue (P/Rev)
3.24 3.20 3.30 3.91 4.17 4.20 4.11 3.77 3.61 4.07 3.55
Price to Earnings (P/E)
20.93 23.96 0.00 0.00 0.00 0.00 0.00 0.00 32.41 65.17 121.28
Dividend Yield
5.08% 5.26% 5.20% 4.38% 4.23% 4.54% 4.66% 5.05% 5.20% 4.62% 5.36%
Earnings Yield
4.78% 4.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.09% 1.53% 0.82%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.12 0.00 0.00 1.22 1.24 1.25 1.24 1.17 1.21 1.15
Enterprise Value to Revenue (EV/Rev)
0.00 7.94 0.00 0.00 8.56 8.75 8.59 8.37 8.06 8.21 7.69
Enterprise Value to EBITDA (EV/EBITDA)
0.00 11.06 0.00 0.00 18.05 17.82 17.49 19.12 11.55 12.40 12.31
Enterprise Value to EBIT (EV/EBIT)
0.00 24.56 0.00 0.00 137.47 111.53 107.05 312.26 28.24 34.81 38.42
Enterprise Value to NOPAT (EV/NOPAT)
0.00 24.56 0.00 0.00 196.38 159.33 152.93 446.09 28.24 34.81 38.42
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 23.17 0.00 0.00 24.16 23.24 22.80 21.98 21.10 22.82 22.13
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 83.31 0.00 0.00 281.24 41.20 41.52
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.86 0.97 1.00 1.02 1.02 1.06 1.09 1.32 1.29 1.21 1.24
Long-Term Debt to Equity
0.86 0.97 1.00 1.02 1.02 1.06 1.09 1.32 1.29 1.21 1.24
Financial Leverage
-0.30 -0.33 -0.33 -1.62 -0.34 1.00 -0.31 -0.32 1.06 1.12 1.15
Leverage Ratio
1.97 2.07 2.01 2.01 2.00 2.08 2.10 2.22 2.22 2.20 2.23
Compound Leverage Factor
1.04 13.18 -2.37 -0.60 -0.82 -3.39 -2.17 5.73 1.85 3.90 6.19
Debt to Total Capital
46.19% 49.15% 50.04% 50.46% 50.44% 51.52% 52.06% 56.81% 56.33% 54.70% 55.45%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
46.19% 49.15% 50.04% 50.46% 50.44% 51.52% 52.06% 56.81% 56.33% 54.70% 55.45%
Preferred Equity to Total Capital
5.15% 5.02% 5.06% 5.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
13.41% 12.76% 12.74% 12.68% 12.74% 13.22% 13.25% 6.89% 6.81% 6.78% 6.61%
Common Equity to Total Capital
35.25% 33.07% 32.16% 31.80% 36.82% 35.26% 34.69% 36.30% 36.86% 38.52% 37.94%
Debt to EBITDA
4.30 4.88 7.13 7.04 7.51 7.46 7.38 9.50 6.00 5.64 5.98
Net Debt to EBITDA
-7.89 4.83 -11.58 -11.42 7.37 7.35 7.24 9.35 5.65 5.55 5.92
Long-Term Debt to EBITDA
4.30 4.88 7.13 7.04 7.51 7.46 7.38 9.50 6.00 5.64 5.98
Debt to NOPAT
9.03 10.85 50.97 49.01 81.68 66.66 64.55 221.78 14.67 15.82 18.67
Net Debt to NOPAT
-16.58 10.74 -82.75 -79.54 80.15 65.74 63.33 218.15 13.82 15.58 18.48
Long-Term Debt to NOPAT
9.03 10.85 50.97 49.01 81.68 66.66 64.55 221.78 14.67 15.82 18.67
Altman Z-Score
0.34 0.21 0.22 0.31 0.34 0.31 0.30 0.24 0.38 0.24 0.14
Noncontrolling Interest Sharing Ratio
33.53% 34.59% 34.63% 35.04% 30.26% 31.21% 31.73% 26.28% 20.70% 15.68% 21.48%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.83 0.15 0.25 0.29 0.28 0.22 0.31 2.77 2.30 0.26 0.18
Quick Ratio
0.47 0.14 0.23 0.27 0.24 0.20 0.21 0.22 0.20 0.22 0.14
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,544 -2,427 2,446 21 -2,368 15 -2,392 -2,404 7.03 -17 -7.83
Operating Cash Flow to CapEx
222.29% 62.30% 111.89% 165.95% 272.73% 182.13% 504.34% 259.69% 374.93% 126.55% 402.99%
Free Cash Flow to Firm to Interest Expense
309.30 -261.18 275.81 2.27 -264.67 2.00 -248.31 -224.13 0.54 -2.12 -0.82
Operating Cash Flow to Interest Expense
3.87 1.30 2.75 2.45 3.61 2.48 2.64 2.36 2.70 1.54 2.24
Operating Cash Flow Less CapEx to Interest Expense
2.13 -0.79 0.29 0.97 2.29 1.12 2.12 1.45 1.98 0.32 1.68
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.14 0.13 0.13 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.14 0.00 0.00 0.15 0.15 0.15
Accounts Payable Turnover
0.27 0.15 0.16 0.17 0.03 0.59 0.60 0.62 0.53 0.16 0.17
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
1,337.24 2,372.05 2,227.50 2,200.40 11,330.57 618.26 607.78 589.97 688.35 2,245.10 2,161.34
Cash Conversion Cycle (CCC)
-1,337.24 -2,372.05 -2,227.50 -2,200.40 -11,330.57 -618.26 -607.78 -589.97 -688.35 -2,245.10 -2,161.34
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-563 1,854 -578 -597 1,809 1,841 1,817 1,802 1,879 1,851 1,821
Invested Capital Turnover
0.38 0.41 0.40 -0.44 0.42 0.14 0.43 0.44 0.15 0.15 0.15
Increase / (Decrease) in Invested Capital
-2,527 2,426 -2,443 -16 2,372 -13 2,396 2,399 70 10 4.06
Enterprise Value (EV)
-344 2,074 -322 -176 2,215 2,284 2,264 2,235 2,204 2,247 2,090
Market Capitalization
859 836 851 1,009 1,078 1,096 1,083 1,007 987 1,114 964
Book Value per Share
$42.81 $40.94 $39.85 $39.38 $43.95 $39.46 $38.07 $42.43 $44.68 $43.05 $41.43
Tangible Book Value per Share
$42.81 $40.94 $39.85 $39.38 $43.95 $39.46 $38.07 $42.43 $44.68 $43.05 $41.43
Total Capital
1,816 1,864 1,849 1,847 1,826 1,854 1,835 1,956 2,031 1,867 1,832
Total Debt
839 916 925 932 921 955 955 1,111 1,144 1,021 1,016
Total Long-Term Debt
839 916 925 932 921 955 955 1,111 1,144 1,021 1,016
Net Debt
-1,540 907 -1,502 -1,512 904 942 937 1,093 1,078 1,006 1,005
Capital Expenditures (CapEx)
14 19 22 14 12 10 5.04 9.73 9.35 10 5.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-63 -63 -55 -53 -61 -59 -58 81 20 -59 -56
Debt-free Net Working Capital (DFNWC)
-10 -53 -41 -37 -44 -46 -40 99 86 -44 -46
Net Working Capital (NWC)
-10 -53 -41 -37 -44 -46 -40 99 86 -44 -46
Net Nonoperating Expense (NNE)
8.23 8.83 7.64 6.70 6.40 7.79 7.50 12 12 14 11
Net Nonoperating Obligations (NNO)
-1,540 907 -1,502 -1,512 904 942 937 957 992 1,006 1,005
Total Depreciation and Amortization (D&A)
25 27 27 26 26 28 28 28 30 30 27
Debt-free, Cash-free Net Working Capital to Revenue
-23.64% -24.02% -21.17% -20.48% -23.58% -22.73% -21.87% 30.44% 7.38% -21.65% -20.57%
Debt-free Net Working Capital to Revenue
-3.95% -20.47% -15.84% -14.51% -16.92% -17.70% -15.01% 37.25% 31.46% -15.93% -16.79%
Net Working Capital to Revenue
-3.95% -20.47% -15.84% -14.51% -16.92% -17.70% -15.01% 37.25% 31.46% -15.93% -16.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.41 ($0.64) ($0.37) ($0.19) ($0.40) ($0.31) ($0.22) ($0.87) $3.22 ($1.11) ($0.77)
Adjusted Weighted Average Basic Shares Outstanding
15.05M 14.99M 14.92M 14.97M 15.53M 15.50M 16.73M 16.74M 16.73M 16.73M 16.78M
Adjusted Diluted Earnings per Share
$0.41 ($0.62) ($0.37) ($0.19) ($0.40) ($0.31) ($0.22) ($0.87) $3.19 ($1.08) ($0.77)
Adjusted Weighted Average Diluted Shares Outstanding
15.05M 17.12M 14.92M 14.97M 15.53M 15.50M 16.73M 16.74M 19.77M 16.78M 16.78M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.05M 14.91M 14.91M 15.30M 16.57M 16.73M 16.74M 16.76M 16.70M 16.77M 16.80M
Normalized Net Operating Profit after Tax (NOPAT)
12 -1.05 2.85 5.03 4.45 2.00 3.32 5.42 60 -7.44 3.00
Normalized NOPAT Margin
18.86% -1.64% 4.42% 7.74% 6.84% 3.01% 4.95% 7.91% 84.20% -11.16% 4.61%
Pre Tax Income Margin
14.20% -14.97% -7.43% -3.29% -3.99% -7.02% -7.29% -25.56% 89.95% -28.29% -23.01%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.11 -0.16 0.46 0.77 0.71 0.38 0.49 -0.63 5.94 -1.29 -0.56
NOPAT to Interest Expense
2.11 -0.11 0.32 0.54 0.50 0.27 0.34 -0.44 5.94 -0.90 -0.39
EBIT Less CapEx to Interest Expense
0.37 -2.25 -2.00 -0.71 -0.61 -0.98 -0.03 -1.54 5.22 -2.51 -1.12
NOPAT Less CapEx to Interest Expense
0.37 -2.20 -2.14 -0.94 -0.83 -1.10 -0.18 -1.35 5.22 -2.12 -0.95
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
107.39% 122.57% -763.60% -841.42% -331.33% -425.32% -443.56% -210.21% 155.96% 283.75% 537.97%
Augmented Payout Ratio
170.55% 146.08% -957.04% -974.76% -383.61% -458.46% -443.56% -210.21% 164.90% 298.79% 537.97%

Financials Breakdown Chart

Key Financial Trends

Note: The JSON data provided appears to be for CenterSpace (CSR), not Investors Real Estate Trust (IRET). MarketBeat will summarize the available CSR data and highlight trends from the last four years. If you have IRET data, share it and I can tailor the analysis directly to IRET.

Here are the top takeaways from the most recent CSR quarterly results, focusing on the last four years of data and highlighting what may matter most to retail investors.

  • Positive net income in Q3 2025: Net income attributable to common shareholders was +$53.78 million, with Basic EPS of $3.22 and Diluted EPS of $3.19, signaling a strong quarterly profit despite prior variability.
  • Consistent operating cash flow across 2025 quarters: Net cash from continuing operating activities was +$34.65 million (Q3 2025) and remained positive in other recent quarters (e.g., +$25.43M in Q1 2025, +$25.27M in Q2 2025, +$12.71M in Q4 2025), indicating ongoing cash generation from core operations.
  • Significant investing cash inflow in Q3 2025: Sale and/or maturity of investments produced a substantial inflow of +$122.35 million, improving near-term liquidity.
  • Strong quarterly earnings metrics in Q3 2025: Diluted EPS of $3.19 and Basic EPS of $3.22 in Q3 2025 reflect solid profitability on a per-share basis for that quarter.
  • Revenue relatively flat recently: Operating revenue has hovered in a narrow range (roughly $66M–$72M) across the latest quarters, suggesting limited near-term topline growth but stable cash generation.
  • High leverage remains a consideration: Long-term debt is substantial (around $1.14B mid-2025), contributing to interest costs and leverage risk even as profits improve.
  • Q4 2025 hit by large non-operating charges: Net income to common shareholders dropped to -$18.43 million in Q4 2025, driven by a large negative Total Other Income / (Expense), net of -$87.76 million and sizable Other Operating Expenses / (Income) of -$62.39 million.
  • Liquidity pressure from the quarter’s cash outlays: Net change in cash and equivalents for Q4 2025 was -$50.19 million, even though operating cash flow remained positive in earlier quarters.
  • Financing activities weighed on cash in Q4 2025: Net cash from financing activities was -$143.05 million in Q4 2025, indicating heavy financing outflows (including debt issuance and repayments), which increases near-term leverage.
05/19/26 11:57 PM ETAI Generated. May Contain Errors.

Centerspace Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Centerspace's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Centerspace's net income appears to be on a downward trend, with a most recent value of $22.96 million in 2025, falling from -$16.94 million in 2014. The previous period was -$14.19 million in 2024. Check out Centerspace's forecast to explore projected trends and price targets.

Centerspace's total operating income in 2025 was $64.54 million, based on the following breakdown:
  • Total Gross Profit: $264.02 million
  • Total Operating Expenses: $199.49 million

Over the last 9 years, Centerspace's total revenue changed from $164.59 million in 2014 to $273.66 million in 2025, a change of 66.3%.

Centerspace's total liabilities were at $1.08 billion at the end of 2025, a 6.5% increase from 2024, and a 13.6% decrease since 2015.

In the past 10 years, Centerspace's cash and equivalents has ranged from $392 thousand in 2020 to $66.70 million in 2016, and is currently $12.83 million as of their latest financial filing in 2025.

Over the last 10 years, Centerspace's book value per share changed from 4.19 in 2015 to 43.05 in 2025, a change of 928.1%.



Financial statements for NYSE:CSR last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners